Image

A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.

Investigating Safety and Efficacy of an Investigational Medication with Radiotherapy for Locally Advanced Pancreatic Cancer

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the safety and tolerability of an investigational medication when used with stereotactic body radiotherapy for locally advanced pancreatic cancer.

The purpose of this study is to evaluate the effectiveness and safety of the combination treatment. It evaluates how well the investigational medication works with radiotherapy in patients with the condition.

  • Who can participate: Adults aged 18 or older with confirmed pancreatic cancer that is locally advanced or unresectable can participate. Key eligibility includes completion of first-line systemic therapy and adequate organ function.
  • Study details: Participants will receive an investigational medication along with radiotherapy.
Print
Study details
    Locally Advanced Pancreatic Adenocarcinoma
    Locally Advanced Pancreas Cancer
    Locally Advanced Pancreatic Ductal Adenocarcinoma

NCT07157033

Xerient Pharma

22 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.